Načítá se...
Antiplatelet and Lipid-lowering Drugs in Hypertension
Antiplatelet therapy, and low-dose acetylsalicylic acid (ASA) in particular, is recommended in hypertensive patients with previous cardiovascular events and is considered in hypertensive patients with reduced renal function or a high cardiovascular (CV) risk, provided blood pressure is well-controll...
Uloženo v:
| Vydáno v: | Eur Cardiol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Radcliffe Cardiology
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6159459/ https://ncbi.nlm.nih.gov/pubmed/30310480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2014.9.1.16 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|